A COMPARATIVE EXPECTED VALUE ANALYSIS STUDY TO DETERMINE IF THE ECONOMIC BENEFITS OF THE MOST COMMONLY PRESCRIBED PRESCRIPTION AND NON-PRESCRIPTION DRUGS IN THE UNITED STATES PROVIDE ECONOMIC VALUE

It was found that anti-biotics, aspirin, bisphosphonates, blood pressure lowering medications, statins, medications treating depression, diabetes, sexual dysfunction and the poly-pill provided economic value, while medications to treat Alzheimer’s, cancer, multiple sclerosis and Clopidogrel were not...

Full description

Saved in:
Bibliographic Details
Published in:Account and Financial Management Journal 2021-10, Vol.6 (10)
Main Author: Anderson, S. Eric
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:It was found that anti-biotics, aspirin, bisphosphonates, blood pressure lowering medications, statins, medications treating depression, diabetes, sexual dysfunction and the poly-pill provided economic value, while medications to treat Alzheimer’s, cancer, multiple sclerosis and Clopidogrel were not found to have provided economic value. The current evidence is insufficient to determine if weight loss medication provides economic value or not
ISSN:2456-3374
2456-3374
DOI:10.47191/afmj/v6i10.02